Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry
Background: Breast cancers with Her-2 neu gene amplification are recognized as important markers for aggressive disease and targets which respond to therapy with trastuzumab. Her-2 neu testing on histological sections is routinely performed to select patients who may benefit from anti- Her-2 neu the...
Main Authors: | Kusum Kapila, S Al-Awadhi, I M Francis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Journal of Cytology |
Subjects: | |
Online Access: | http://www.jcytol.org/article.asp?issn=0970-9371;year=2011;volume=28;issue=2;spage=54;epage=56;aulast=Kapila |
Similar Items
-
Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01) -
Inter-observer agreement in reporting HER 2 Neu protein over expression by immunohistochemistry
by: Ibrahim Al Haddabi, et al.
Published: (2014-01-01) -
Hormone receptors and human epidermal growth factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma – Role in patient management
by: Issam M Francis, et al.
Published: (2019-01-01) -
Immunocytochemistry: It′s role in diagnosis of undifferentiated neoplasms by fine needle aspiration cytology
by: Palash Kumar Mandal, et al.
Published: (2013-01-01) -
Study of human epidermal growth factor receptor (HER2/neu) expression in primary colorectal carcinoma in a tertiary care hospital
by: Mousmi Agrawal, et al.
Published: (2021-01-01)